| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |